| GC16394-10mg |
|
130663-39-7 |
|
0 |
C31H32N4O3 |
|
|
|
| GC16394-5mg |
|
130663-39-7 |
|
0 |
C31H32N4O3 |
|
|
|
| GC16392-200mg |
|
1246525-60-9 |
|
0 |
C17H10F9NO2 |
|
|
|
| GC16392-50mg |
|
1246525-60-9 |
|
0 |
C17H10F9NO2 |
|
|
|
| GC16392-10mg |
|
1246525-60-9 |
|
0 |
C17H10F9NO2 |
|
|
|
| GC16392-5mg |
|
1246525-60-9 |
|
0 |
C17H10F9NO2 |
|
|
|
| GC16391-10mM (in 1mL DMSO) |
|
850879-09-3 |
Amuvatinib (MP-470, HPK 56)
|
0 |
C23H21N5O3S |
|
|
|
| GC16391-50mg |
|
850879-09-3 |
Amuvatinib (MP-470, HPK 56)
|
0 |
C23H21N5O3S |
|
|
|
| GC16391-10mg |
|
850879-09-3 |
Amuvatinib (MP-470, HPK 56)
|
0 |
C23H21N5O3S |
|
|
|
| GC16391-5mg |
|
850879-09-3 |
Amuvatinib (MP-470, HPK 56)
|
0 |
C23H21N5O3S |
|
|
|
| GC16391-2mg |
|
850879-09-3 |
Amuvatinib (MP-470, HPK 56)
|
0 |
C23H21N5O3S |
|
|
|
| GC16390-10mM (in 1mL DMSO) |
|
132112-35-7 |
Ropivacaine hydrochloride monohydrate
|
0 |
C17H29ClN2O2 |
|
|
|
| GC16390-50mg |
|
132112-35-7 |
Ropivacaine hydrochloride monohydrate
|
0 |
C17H29ClN2O2 |
|
|
|
| GC16389-25mg |
|
732983-37-8 |
|
0 |
C20H18N6O3 |
|
|
|
| GC16389-100mg |
|
732983-37-8 |
|
0 |
C20H18N6O3 |
|
|
|
| GC16389-10mg |
|
732983-37-8 |
|
0 |
C20H18N6O3 |
|
|
|
| GC16389-5mg |
|
732983-37-8 |
|
0 |
C20H18N6O3 |
|
|
|
| GC16388-10mM (in 1mL DMSO) |
|
603139-19-1 |
|
0 |
C25H27F4N3O3S |
|
|
|
| GC16388-10mg |
|
603139-19-1 |
|
0 |
C25H27F4N3O3S |
|
|
|
| GC16388-100mg |
|
603139-19-1 |
|
0 |
C25H27F4N3O3S |
|
|
|
